Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CSDA |
| Upstream (Parents) |
|---|
| (<<) HOXA9 → CSDA |
| (<<) ONECUT1 → CSDA |
| (<<) ESR1 → CSDA |
| (<<) ATF5 → CSDA |
| (<<) HOXA10 → CSDA |
| (<<) AR → CSDA |
| (<<) MAFF → CSDA |
| (<<) FOXM1 → CSDA |
| (<<) ZGPAT → CSDA |
| (<<) KLF11 → CSDA |
| Downstream (Children) |
|---|
| CSDA → SATB2 (>>) |
| CSDA → LHX2 (>>) |
| CSDA → NR5A2 (>>) |
| CSDA → LEF1 (>>) |
| CSDA → TCF21 (>>) |
| CSDA → MSX1 (>>) |
| CSDA → SIX1 (>>) |
| CSDA → VDR (>>) |
| CSDA → MLL (>>) |
| CSDA → MYOG (>>) |
| CSDA → HCFC1 (>>) |
| CSDA → ZNF165 (>>) |
| CSDA → KLF4 (>>) |
| CSDA → FOXP3 (>>) |
| CSDA → SRF (>>) |
| CSDA → FOXF1 (>>) |
| CSDA → ZNF83 (>>) |
